[1]孙长青,李 敏,孟令军,等.生长激素释放肽、褪黑素在年轻宫颈癌患者化疗后血清中的水平变化及其与卵巢储备功能相关性研究[J].陕西医学杂志,2025,54(2):205-208,213.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.012]
　SUN Changqing,LI Min,MENG Lingjun,et al.Changes in serum levels of Ghrelin and melatonin in young patients with cervical cancer after chemotherapy and their correlation with ovarian reserve function[J].,2025,54(2):205-208,213.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.012]
点击复制

生长激素释放肽、褪黑素在年轻宫颈癌患者化疗后血清中的水平变化及其与卵巢储备功能相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年2期
页码:
205-208,213
栏目:
临床研究
出版日期:
2025-02-05

文章信息/Info

Title:
Changes in serum levels of Ghrelin and melatonin in young patients with cervical cancer after chemotherapy and their correlation with ovarian reserve function
作者:
孙长青; 李 敏; 孟令军; 刘 翠; 张 娜
(山东大学齐鲁医院德州医院,山东 德州 253000)
Author(s):
SUN Changqing; LI Min; MENG Lingjun; LIU Cui; ZHANG Na
(Qilu Hospital of Shandong University Dezhou Hospital,Dezhou 253000,China)
关键词:
宫颈癌;  生长激素释放肽;  褪黑素;  卵巢储备功能;  影响因素;  预测价值
Keywords:
Cervical cancer;  Ghrelin;  Melatonin;  Ovarian reserve function;  Influencing factors;  Predictive value
分类号:
R 737.33
DOI:
DOI:10.3969/j.issn.1000-7377.2025.02.012
文献标志码:
A
摘要:
目的:探讨生长激素释放肽(Ghrelin)、褪黑素(MT)在年轻宫颈癌患者化疗后血清中的水平变化及其与卵巢储备功能的相关性。方法:选取接受化疗的年龄在18～35岁的宫颈癌患者156例为研究对象,根据化疗3个月后卵巢储备功能是否下降将患者分为功能减退组(95例)和功能正常组(61例)。比较两组临床资料及血清Ghrelin、MT水平。采用Logistic回归分析宫颈癌患者化疗后卵巢储备功能减退的影响因素。采用Pearson法分析患者血清Ghrelin、MT与卵泡刺激素(FSH)、FSH/黄体生成素(LH)、雌二醇(E2)、抗米勒管激素(AMH)水平的相关性。绘制受试者工作特征(ROC)曲线分析血清Ghrelin、MT对宫颈癌患者化疗后卵巢储备功能减退的预测价值。结果:与功能正常组比较,功能减退组患者血清FSH、E2水平、FSH/LH比值升高,AMH水平降低(均P<0.05)。功能减退组患者血清Ghrelin和MT水平低于功能正常组(均P<0.05)。血清Ghrelin、MT、FSH、FSH/LH、E2和AMH是宫颈癌患者化疗后卵巢储备功能减退的影响因素(均P<0.05)。血清Ghrelin、MT与FSH、FSH/LH、E2水平呈负相关,与AMH水平呈正相关(均P<0.05)。血清Ghrelin、MT联合预测宫颈癌患者化疗后卵巢储备功能减退的曲线下面积(AUC)大于两者单独预测的AUC(均P<0.05)。结论:年轻宫颈癌患者化疗后血清Ghrelin、MT水平降低,是患者化疗后卵巢储备功能减退的影响因素,且两者联合对化疗后卵巢储备功能减退的预测价值较高。
Abstract:
Objective:To explore the changes in serum levels of Ghrelin and melatonin(MT)in young patients with cervical cancer after chemotherapy and their correlation with ovarian reserve function.Methods:A total of 156 cervical cancer patients aged 18 to 35 who underwent chemotherapy were selected as the study subjects.According to whether the ovarian reserve function decreased after 3 months of chemotherapy,the patients were divided into the function decline group(95 cases)and the function normal group(61 cases).Clinical data and serum levels of Ghrelin and MT were compared between the two groups.Logistic regression analysis was used to identify factors affecting the decline in ovarian reserve function after chemotherapy in cervical cancer patients.Pearson's correlation analysis was used to assess the correlation between serum Ghrelin and MT levels and follicle-stimulating hormone(FSH),FSH/luteinizing hormone(LH),estradiol(E2),and anti-Müllerian hormone(AMH)levels.The receiver operating characteristic(ROC)curve was plotted to analyze the predictive value of serum Ghrelin and MT for the decline in ovarian reserve function after chemotherapy in cervical cancer patients.Results:Compared with the function normal group,the function decline group had increased serum levels of FSH and E2,an increased FSH/LH ratio,and decreased AMH levels(all P<0.05).Patients in the function decline group had lower serum levels of Ghrelin and MT than those in the function normal group(all P<0.05).Serum Ghrelin,MT,FSH,FSH/LH,E2 and AMH were factors affecting the decline in ovarian reserve function after chemotherapy in cervical cancer patients(all P<0.05).Serum Ghrelin and MT were negatively correlated with FSH,FSH/LH and E2 levels,and positively correlated with AMH levels(all P<0.05).The combined predictive AUC for serum Ghrelin and MT for the decline in ovarian reserve function after chemotherapy in cervical cancer patients was greater than that of individual predictions(all P<0.05).Conclusion:Decreased serum levels of Ghrelin and MT in young cervical cancer patients after chemotherapy are factors affecting the decline in ovarian reserve function,and their combination has a high predictive value for the decline in ovarian reserve function after chemotherapy.

参考文献/References:

[1] 刘丹,程雪花.年轻女性宫颈癌患者临床特征与早期宫颈癌预后因素分析[J].热带医学杂志,2017,17(1):32-34.
[2] 吴侠,宋红娟,刘晴晴,等.局部晚期宫颈癌患者新辅助化疗疗效的影响因素及预测模型研究[J].中国现代医学杂志,2023,33(20):14-19.
[3] 魏敏,胡慧勇,王海荣,等.经阴道彩超及AMH、FSH水平对不孕患者卵巢储备功能的评定分析[J].中国性科学,2020,29(12):69-72.
[4] 陈保利,刘兰苑,伍德英,等.经阴道超声检查联合AMH、雌激素对卵巢储备功能的评估价值[J].临床医学研究与实践,2023,8(10):93-96.
[5] 蔡斌,刘雪莲,杨懿霞.GDF-9、Ghrelin的表达与控制性排卵多囊卵巢综合征患者IVF-ET治疗结局的关系[J].临床和实验医学杂志,2022,21(3):277-281.
[6] 崔美静,项莹.生长激素释放多肽在多囊卵巢综合征中的研究进展[J].医学综述,2017,23(12):2447-2452.
[7] 沈云燕,邱琦.褪黑素联合顺铂对宫颈癌HeLa细胞增殖、凋亡及侵袭的影响[J].生物技术进展,2023,13(2):311-317.
[8] 范艺辉,赖东梅.褪黑素调节卵巢功能及相关机制的研究进展[J].中国细胞生物学学报,2020,42(3):525-533.
[9] 中国抗癌协会妇科肿瘤专业委员会.宫颈癌诊断与治疗指南(第4版)[J].中国实用妇科与产科杂志,2018,34(6):613-622.
[10] 谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:245-248.
[11] ALESI L R,NGUYEN Q N,STRINGER J M,et al.The future of fertility preservation for women treated with chemotherapy[J].Reprod Fertil,2023,4(2):e220123.
[12] 冯敏娟,蔡东阁,李虹.转录因子7-like 2在宫颈癌中表达水平及其与顺铂化疗敏感性关系研究[J].陕西医学杂志,2024,53(10):1335-1339.
[13] KUCERA M,STEPAN M J,STELCL M.Possibilities and real meaning of assessment of ovarian reserve[J].Ceska Gynekol,2018,83(4):307-311.
[14] 胡淑玲,王韫琪,田丹.温经汤加减治疗肾虚血瘀型卵巢储备功能减退疗效及对患者子宫动脉血流和卵巢功能的影响[J].陕西中医,2023,44(10):1395-1399.
[15] 吴斯瑶,郑晓林,徐秋红,等.经阴道三维超声联合抗苗勒管激素在卵巢储备功能评估中的应用价值[J].中华医学超声杂志:电子版,2019,16(2):131-137.
[16] 陈昌钊,吴汤娜,符叶柳,等.女性基础性激素、抗苗勒管激素水平联合经阴道三维超声在卵巢储备功能评估中的作用[J].中华医学超声杂志:电子版,2020,17(12):1208-1212.
[17] 冯海鹰,黄东明.Ghrelin与炎症发病机制的研究进展[J].内科,2024,19(1):72-77.
[18] 韩静,徐鑫,孙云霞.调气和胃汤联合针刺治疗脾虚气滞型功能性消化不良疗效及对患者胃肠激素的影响[J].陕西中医,2024,45(5):622-626.
[19] LEE J H,PATEL K,TAE H J,et al.Ghrelin augments murine T-cell proliferation by activation of the phosphatidylinositol-3-kinase,extracellular signal-regulated kinase and protein kinase C signaling pathways[J].FEBS Lett,2014,588(24):4708-4719.
[20] GAJEWSKA A,STRZELECKI D,GAWLIK-KOTELNICKA O.Ghrelin as a biomarker of “immunometabolic depression” and its connection with dysbiosis[J].Nutrients,2023,15(18):3960.
[21] 曾克非,夏婷婷.右美托咪定对绝经前期腹腔镜子宫肌瘤切除术患者麻醉诱导期镇痛及应激反应的影响[J].陕西医学杂志,2021,50(11):1433-1436,1445.
[22] TAMURA H,KAWAMOTO M,SATO S,et al.Long-term melatonin treatment delays ovarian aging[J].J Pineal Res,2017,62(2):1-23.
[23] QI M K,SUN T C,YANG L Y,et al.Therapeutic effect of melatonin in premature ovarian insufficiency:Hippo pathway is involved[J].Oxid Med Cell Longev,2022,2022:3425877.
[24] YANG C,LIU Q,CHEN Y,et al.Melatonin delays ovarian aging in mice by slowing down the exhaustion of ovarian reserve[J].Commun Biol,2021,4(1):534.
[25] XIE Q E,WANG M Y,CAO Z P,et al.Melatonin protects against excessive autophagy-induced mitochondrial and ovarian reserve function deficiency though ERK signaling pathway in Chinese hamster ovary(CHO)cells[J].Mitochondrion,2021,61:44-53.

相似文献/References:

[1]李 虎,杨 翔,冯凯勋,等.循环肿瘤细胞检测对宫颈癌患者预后的判断价值[J].陕西医学杂志,2021,50(4):492.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.029]
[2]梁 媛,蔡江义,谢 云,等.DNA倍体分析联合血清肿瘤标志物筛查宫颈癌价值研究[J].陕西医学杂志,2021,50(10):1296.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.031]
[3]王 静,袁 渊,周 敏,等.细胞周期蛋白依赖性激酶亚基2通过干预线粒体功能促进宫颈癌细胞增殖机制研究[J].陕西医学杂志,2022,51(2):136.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.002]
　WANG Jing,YUAN Yuan,ZHOU Min,et al.CKS2 promotes the proliferation of cervical cancer cells by interfering with mitochondrial function[J].,2022,51(2):136.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.002]
[4]吕瑜玫,陈 丹,朱 桥,等.宫颈癌患者血清微小核糖核酸-381、微小核糖核酸-145水平变化及与临床病理参数相关性分析[J].陕西医学杂志,2023,52(7):925.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.034]
　LYU Yumei,CHEN Dan,ZHU Qiao,et al.Changes of serum microRNA-381 and microRNA-145 levels and their correlation with clinicopathological parameters in patients with cervical cancer[J].,2023,52(2):925.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.034]
[5]袁浩鑫,冯一平,王思雨,等.调控miR-642a-5p表达对宫颈癌HeLa细胞生物学行为的影响及机制研究[J].陕西医学杂志,2023,52(11):1498.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.010]
　YUAN Haoxin,FENG Yiping,WANG Siyu,et al.Effects and mechanism of regulating miR-642a-5p expression on biological behavior of cervical cancer HeLa cells[J].,2023,52(2):1498.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.010]
[6]常娟娟,李太平,康婉英,等.容积旋转调强与调强放疗在宫颈癌放疗中的应用及剂量学、安全性研究[J].陕西医学杂志,2024,(2):194.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.010]
　CHANG Juanjuan,LI Taiping,KANG Wanying,et al.Application,dosimetric and safety analysis of volumetric modulated arc therapy and intensity modulated radiation therapy in radiotherapy of cervical cancer[J].,2024,(2):194.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.010]
[7]惠玉洁,朱林凤,李卫民,等.宫颈癌患者血清微小RNA-195、双皮质素样激酶1、鳞状细胞癌抗原表达水平与临床病理特征及预后相关性研究[J].陕西医学杂志,2024,(5):696.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.027]
　HUI Yujie,ZHU Linfeng,LI Weimin,et al.Relationship between serum microRNA-195,doublecortin-like kinase 1,squamous cell carcinoma antigen levels and clinicopathological featuresand prognosis in patients with cervical cancer[J].,2024,(2):696.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.027]
[8]季 滢,郑艳莉,韩 云,等.尼美舒利对宫颈癌荷瘤裸鼠移植瘤的影响及机制实验研究[J].陕西医学杂志,2024,(8):1026.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.004]
　JI Ying,ZHENG Yanli,HAN Yun,et al.Effect of nimesulide on cervical cancer tumor-bearing nude mice xenograft and its mechanism[J].,2024,(2):1026.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.004]
[9]冯敏娟,蔡东阁,李 虹.转录因子7-like 2在宫颈癌中表达水平及其与顺铂化疗敏感性关系研究[J].陕西医学杂志,2024,(10):1335.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.008]
　FENG Minjuan,CAI Dongge,LI Hong.Expression level of transcription factor 7-like 2 in cervical cancer and its relationship with cisplatin chemotherapy sensitivity[J].,2024,(2):1335.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.008]
[10]秦 杰,张一娇,路晓琳,等.基于液基细胞学的hWAPL蛋白检验在高危型人乳头瘤病毒感染患者宫颈癌筛查中的价值研究[J].陕西医学杂志,2025,54(2):268.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.026]
　QIN Jie,ZHANG Yijiao,LU Xiaolin,et al.Value of hWAPL protein test based on liquid-based cytology in cervical cancer screening in high-risk human papillomavirus infected patients[J].,2025,54(2):268.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.026]

备注/Memo

备注/Memo:
[基金项目]山东省医药卫生科技发展计划项目(2018WS522)
更新日期/Last Update: 2025-02-04